PATENT CLAIM ANALYSIS

Application Number: 16005349
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2019-04
Patent Classification: ["544", "101000"]

Abstract:
The present invention provides a combination of at least one oxazolidinone-quinolone hybrid with at least one further antibacterial compound and the use thereof as drug, especially for the treatment or prophylaxis of bacterial infections.

Claim (Index 17):
A method for treating a subject suffering from or susceptible to a bacterial infection, comprising administering to the subject a pharmaceutical composition of  claim 13 .

Metadata:
- Claim Count in Document: 46.0
- Percentile: 94.0
- Lexical Diversity: 1.16129
- Patent Class: 544.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['14894408', '14773603', '13989600', '14110818', '14872988']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7400726564697466
- 35 USC 102 Novelty (BERT): 0.5964818847931722
- Combined Prediction Score: 0.7257135793020891
- Mean Citation Score: 340.4518700000001
- Max Citation Score: 532.22003
- Similarity Product: 445.6193625056076

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test